Arachidonic acid (AA) and docosahexaenoic acid (DHA) decrease the risk for severe retinopathy of prematurity (ROP) in extremely preterm infants by nearly half, according to a research letter published online in JAMA Ophthalmology.
This article was originally published on MedicalXpress.com

